Friday, 30 September 2016

Depomed wins Nucynta patent dispute

(Reuters) - Depomed Inc said a court ruled in favor of the drug maker in a patent litigation over its opioid drug, Nucynta, extending its market exclusivity until 2025.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)